These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8474088)

  • 21. Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience.
    Jois RN; Masding A; Somerville M; Gaffney K; Scott DG
    Rheumatology (Oxford); 2007 Jun; 46(6):980-2. PubMed ID: 17384180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does cyclophosphamide combined with methylprednisolone affect the expression of leukocyte function associated antigen 1 in refractory rheumatoid arthritis.
    Lacki JK; Müller-Ruchholtz W; Mackiewicz SH
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):285-8. PubMed ID: 9523002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.
    Anderson JJ; Bolognese JA; Felson DT
    Arthritis Rheum; 2003 Nov; 48(11):3031-8. PubMed ID: 14613263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measure of bone loss in rheumatoid arthritis].
    Náfrádi L; Toldy E; Varga L
    Orv Hetil; 1999 Feb; 140(6):281-4. PubMed ID: 10071506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
    Porter D
    Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent postpartum episodic rheumatoid arthritis.
    Hammoudeh M
    J Clin Rheumatol; 2006 Aug; 12(4):196-8. PubMed ID: 16891925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 28. Rheumatoid arthritis. Outcome measures.
    Paulus HE; Bulpitt KJ
    Rheum Dis Clin North Am; 1995 Aug; 21(3):605-18. PubMed ID: 8619091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of drug responses in the patient severely afflicted with rheumatoid arthritis.
    Slonim RR; Kiem IM; Howell DS; Brown HE
    J Fla Med Assoc; 1969 May; 56(5):336-41. PubMed ID: 5798133
    [No Abstract]   [Full Text] [Related]  

  • 30. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.
    Harrison MJ; Tricker KJ; Davies L; Hassell A; Dawes P; Scott DL; Knight S; Davis M; Mulherin D; Symmons DP
    J Rheumatol; 2005 Dec; 32(12):2330-6. PubMed ID: 16331758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenteral administration of 6-alpha-methylprednisolone-21-acetate. II. Absorption and duration of effect.
    Bain LS; Jacomb RG; Wynn V
    Ann Phys Med; 1967 May; 9(2):49-54. PubMed ID: 6026697
    [No Abstract]   [Full Text] [Related]  

  • 32. Tight control in rheumatoid arthritis improves outcomes.
    Ostör AJ; Conaghan PG
    Practitioner; 2009 Mar; 253(1716):29-32. PubMed ID: 19418700
    [No Abstract]   [Full Text] [Related]  

  • 33. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.
    Wolfe F; Michaud K
    Rheumatology (Oxford); 2005 Dec; 44 Suppl 4():iv18-iv22. PubMed ID: 16306476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of clarithromycin in patients with active rheumatoid arthritis.
    Ogrendik M
    Curr Med Res Opin; 2007 Mar; 23(3):515-22. PubMed ID: 17355733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in clinical and laboratory findings on oxidation metabolism in lymphocyte membranes of rheumatoid arthritis patients on synchronous programmed intensive therapy].
    Lushpaeva IuA; Medvedeva IV; Fadienko GR
    Klin Med (Mosk); 2002; 80(5):39-42. PubMed ID: 12087885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IV methylprednisolone and nitrogen mustard.
    Rothschild BM
    J Rheumatol; 1991 May; 18(5):784-5. PubMed ID: 1865436
    [No Abstract]   [Full Text] [Related]  

  • 37. Nitrogen mustard and methylprednisolone in severe rheumatoid arthritis.
    Kalra M; Blake AE; Scott DL; Popert AJ
    Clin Rheumatol; 1984 Dec; 3(4):554-5. PubMed ID: 6396022
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of rheumatoid arthritis with the dopamine agonist quinagolide.
    Eijsbouts A; van den Hoogen F; Laan RF; Hermus RM; Sweep FC; van de Putte L
    J Rheumatol; 1999 Oct; 26(10):2284-5. PubMed ID: 10529161
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complete atrioventricular block in a patient with rheumatoid arthritis].
    Ozgül M; Hoşcan Y; Arslan C; Karabacak M
    Turk Kardiyol Dern Ars; 2008 Jun; 36(4):263-5. PubMed ID: 18765972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.
    Simon LS; Lanza FL; Lipsky PE; Hubbard RC; Talwalker S; Schwartz BD; Isakson PC; Geis GS
    Arthritis Rheum; 1998 Sep; 41(9):1591-602. PubMed ID: 9751091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.